Sire Bioscience (SIRE)

[100% CORRECT DD]

Blox Labs Receives CSE Approval for Change of Business And Name Change to Sire Bioscience Inc.
September 9, 2019 - Toronto, Ontario – Blox Labs Inc. (“Blox” or “the Company”) (CSE: BLOX) (Frankfurt: BR1B) (OTC:BLLXF) is pleased to announce that further to its news release dated August 29, 2019, the Company has completed all matters relating to its change of business, including receiving final approval from the Canadian Securities Exchange (“CSE”), completion of a name change to Sire Bioscience Inc. (“Sire”), and pursuant to a CSE bulletin, will commence trading on the CSE under the symbol SIRE on September 11, 2019. The Company will also affect management changes in conjunction with the completion of the transaction. On the listing date, the Board of Directors of Sire will consist of:
• Brian Polla, COO and director
• Jeff Zanini, CEO and director
• Sean McGrath, CFO
• Jerry Habuda, director
• Adrian Burke, director
• Brian Nugent , director
The Company has officially launched its new website at www.sirebioscience.com.

About Sire Bioscience Inc.
Sire is Canadian life sciences company with a focus on the cultivation, production and sale of industrial hemp. Sire is headquartered in Toronto, Ontario and it owns a 50-acre parcel of land, inclusive of a 160,000 sq. ft. state-of-the-art greenhouse, in Leamington, Ontario – a preeminent locale for hemp cultivation in Canada.

For additional information:
Sire Bioscience Inc.
Jeff Zanini
CEO
E: [e-mail]
T: 416-262-0871